Erysipelas Bullosa in a Patient with Deep Vein Thrombosis: A Case Report

Authors

  • Dina Arwina Dalimunthe Department of Dermatology and Venereology, Faculty of Medicine, Universitas Sumatera Utara, Uni-versitas Sumatera Utara Hospital, Medan, Indonesia
  • Annisa Astari Resident Department of Dermatology and Venereology, Faculty of Medicine, Universitas Sumatera Utara, Universitas Suma-tera Utara Hospital, Medan, Indonesia

Keywords:

Erysipelas, Bullous, Staphylococcus aureus, Deep Vein Thrombosis

Abstract

Erysipelas is an extensive skin infection usually affecting the legs or face, caused by group A β-hemolytic streptococci. Erysipelas bullosa is a severe form of the disease. We report a case of Erysipelas Bullosa in a Patient with Deep Vein Thrombosis (DVT) in a 43-year-old Asian male who presented with well-demarcated erythematous macules with vesicles and bullae on an erythematous base in the left crural region. This case was diagnosed based on anamnesis, physical examination, and bacterial culture. The patient was treated with intravenous antibiotics.

References

Krasagakis K, Samonis G, Maniatakis P, Georgala S, Tosca A. Bullous Erysipelas: Clinical Presentat-ion, Staphylococcal Involvement and Methicillin Resistance. Dermatology. 2006; 212(1): 31-5.

doi: 10.1159/000089019

Brishkoska-Boshkovski V, Kondova-Topuzovska I, Damevska K, Petrov A. Comorbidities as Risk Factors for Acute and Recurrent Erysipelas. Open Access Maced J Med Sci. 2019;7(6):937-942.

doi: 10.3889/oamjms.2019.214..

Blaivas M, Lyon M, Pollack CV Jr, Howell JM. Deep vein thrombosis: identifying the killer before it strikes. Emerg Med Pract 2005; 7: 1–20.

Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003; 107: 1–16.

Boshkovski VB, Topuzovska IK, Damevska K, Pet-rov A. Comorbidities as Risk Factors for Acute and Recurrent Erysipelas. Open Access Maced J Med Sci. 2019; 7(6): 937-42.

Drerup C, Eveslage M, Sunderkoetter C, Ehrchen J. Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis. J Dtsch Dermatol Ges. 2020;18(12):1417-1424. doi: 10.1111/ddg.14252.

Sager R, Kutz A, Mueller B, Schuetz P. Procalcitonin-guided diagnosis and antibiotic stewardship revisited. BMC Med. 2017;15(1):15. doi: 10.1186/s12916-017-0795-7.

Gunderson CG, Chang JJ. Risk of deep vein thrombosis in patients with cellulitis and erysipelas: a systematic review and meta-analysis. Thromb Res. 2013;132(3):336-40.

doi: 10.1016/j.thromres.2013.07.021

Mortazavi M. Samiee MM, Spencer FA. Incidence of deep vein thrombosis in erysipelas or cellulitis of the lower extremities. Int J Dermatol. 2013; 52(3): 279-85. doi: 10.1111/j.1365-4632.2012.05619.x

Pearson DR, Margolis DJ. Cellulitis and Erysi-pelas. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitxpatrick’s Dermatology in General Medicine. 9th ed. New York McGraw-Hill; 2019: p. 2746-54.

Downloads

Published

2025-12-31

How to Cite

1.
Dalimunthe DA, Astari A. Erysipelas Bullosa in a Patient with Deep Vein Thrombosis: A Case Report. J Pak Assoc Dermatol [Internet]. 2025Dec.31 [cited 2026Jan.21];35(4):363-6. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/2909

Issue

Section

Case Reports